SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001333277-21-000034
Filing Date
2021-04-05
Accepted
2021-04-05 16:41:57
Documents
2
Period of Report
2021-04-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1626
2 attachment_1.htm EX-24 3113
  Complete submission text file 0001333277-21-000034.txt   6175
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Issuer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
WIGGANS THOMAS G (Reporting) CIK: 0001208907 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36500 | Film No.: 21806004